Search research articles
Contact Us
Filters
Showing results (111-120 of 246) with videos related to
Page
of 25
Sort By:
Frontiers in Oncology
|
January 19, 2024
Adverse events of immune checkpoint therapy alone versus when combined with vascular endothelial growth factor inhibitors: a pooled meta-analysis of 1735 patients
Iuliia Kovalenko, Wern Lynn Ng, Yimin Geng, et al.
Current Oncology (Toronto, Ont.)
|
March 28, 2023
Renal Cell Carcinoma Unclassified with Medullary Phenotype in a Patient with Neurofibromatosis Type 2
Sanila Sarkar, Whitney Throckmorton, Racheal Bingham, et al.
Oncotarget
|
May 5, 2016
Analysis of overall survival in a large multiethnic cohort reveals absolute neutrophil count of 1,100 as a novel prognostic cutoff in African Americans
Ioannis Mantzaris, Yiting Yu, Pavlos Msaouel, et al.
Acta Oncologica (Stockholm, Sweden)
|
March 24, 2025
Treatment group-specific inferences in Phase III Randomized Oncology Trials
Alexander D Sherry, Adina H Passy, Joseph Abi Jaoude, et al.
Cancers
|
August 12, 2023
A Phase II Clinical Trial of Pembrolizumab Efficacy and Safety in Advanced Renal Medullary Carcinoma
Chijioke Nze, Pavlos Msaouel, Mohamed H Derbala, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 24, 2022
Evolving Role of Adjuvant Systemic Therapy for Kidney and Urothelial Cancers
Andrea B Apolo, Pavlos Msaouel, Scot Niglio, et al.
Anticancer Research
|
March 6, 2014
Kiss-1/GPR54 protein expression in breast cancer
Eleni Papaoiconomou, Maria Lymperi, Constantina Petraki, et al.
Cancers
|
May 13, 2026
Kidney Cancer Trends, Risk Factors, and Interventions in American Indian and Alaska Native Populations: The Kidney Cancer Association Scientific Statement
Salvatore La Rosa, Pavlos Msaouel, Andrew J Sedgewick, et al.
Urologic Oncology
|
January 9, 2025
Concomitant antihistamine administration is associated with improved survival outcomes in patients with locally advanced or metastatic urothelial carcinoma treated with atezolizumab. Analysis of individual participant data from IMvigor210 and IMvigor211
Giuseppe Fallara, Federico Belladelli, Daniele Robesti, et al.
Cancer Medicine
|
August 29, 2025
Patient, Physician, and Assessor Blinding in Phase III Randomized Trials in Oncology: A Meta-Epidemiological Analysis
Gabrielle Brown, Pavlos Msaouel, Avital M Miller, et al.
Page
of 25
Search research articles
Search
Showing results (111-120 of 246) with videos related to
Sort By:
Page
of 25
Frontiers in Oncology
|
January 19, 2024
Adverse events of immune checkpoint therapy alone versus when combined with vascular endothelial growth factor inhibitors: a pooled meta-analysis of 1735 patients
Iuliia Kovalenko, Wern Lynn Ng, Yimin Geng, et al.
Current Oncology (Toronto, Ont.)
|
March 28, 2023
Renal Cell Carcinoma Unclassified with Medullary Phenotype in a Patient with Neurofibromatosis Type 2
Sanila Sarkar, Whitney Throckmorton, Racheal Bingham, et al.
Oncotarget
|
May 5, 2016
Analysis of overall survival in a large multiethnic cohort reveals absolute neutrophil count of 1,100 as a novel prognostic cutoff in African Americans
Ioannis Mantzaris, Yiting Yu, Pavlos Msaouel, et al.
Acta Oncologica (Stockholm, Sweden)
|
March 24, 2025
Treatment group-specific inferences in Phase III Randomized Oncology Trials
Alexander D Sherry, Adina H Passy, Joseph Abi Jaoude, et al.
Cancers
|
August 12, 2023
A Phase II Clinical Trial of Pembrolizumab Efficacy and Safety in Advanced Renal Medullary Carcinoma
Chijioke Nze, Pavlos Msaouel, Mohamed H Derbala, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 24, 2022
Evolving Role of Adjuvant Systemic Therapy for Kidney and Urothelial Cancers
Andrea B Apolo, Pavlos Msaouel, Scot Niglio, et al.
Anticancer Research
|
March 6, 2014
Kiss-1/GPR54 protein expression in breast cancer
Eleni Papaoiconomou, Maria Lymperi, Constantina Petraki, et al.
Cancers
|
May 13, 2026
Kidney Cancer Trends, Risk Factors, and Interventions in American Indian and Alaska Native Populations: The Kidney Cancer Association Scientific Statement
Salvatore La Rosa, Pavlos Msaouel, Andrew J Sedgewick, et al.
Urologic Oncology
|
January 9, 2025
Concomitant antihistamine administration is associated with improved survival outcomes in patients with locally advanced or metastatic urothelial carcinoma treated with atezolizumab. Analysis of individual participant data from IMvigor210 and IMvigor211
Giuseppe Fallara, Federico Belladelli, Daniele Robesti, et al.
Cancer Medicine
|
August 29, 2025
Patient, Physician, and Assessor Blinding in Phase III Randomized Trials in Oncology: A Meta-Epidemiological Analysis
Gabrielle Brown, Pavlos Msaouel, Avital M Miller, et al.
Page
of 25